Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q3 2023 Earnings

8NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.86

-0.64

-0.41

-0.19

Details

Expected EPS

-0.57

Actual EPS

-0.46

Surprise EPS

0.11

Surprise Percent

+19.3%

Description

Fate Therapeutics (FATE) has reported earnings of -0.46 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.